AGIO
Agios Pharmaceuticals, Inc.
32.60$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -90.8% | -130.2% | 55.2% | -663.2% | -322.5% | -314.3% | -143.1% | -983,650.9% | -2,173.3% | -1,103.8% | -1,068.1% | -690.3% | |
| 2.1% | 5.7% | 8.2% | 15.0% | 7.6% | 6.9% | 9.2% | 22,314.0% | 60.1% | 24.7% | 15.5% | 9.6% | |
| 17.6% | 54.1% | 60.2% | 111.2% | 77.7% | 61.4% | 30.3% | 129,218.3% | 346.2% | 166.9% | 117.4% | 97.3% | |
| 18.4% | 54.1% | 60.2% | 111.2% | 77.7% | 62.3% | 37.0% | -95,906.7% | 345.8% | – | – | – | |
| -29.5% | 8.3% | 269.7% | -57.7% | -37.2% | -39.0% | 1.0% | -88,922.7% | -115.4% | -71.0% | -54.2% | -61.2% | |
| 3.4% | 34.1% | 14.2% | 10.8% | 7.4% | 10.3% | 6.9% | 13,864.1% | 34.3% | 3.7% | 4.6% | 8.0% | |
| -510.0% | 217.0% | -170.8% | -134.6% | -290.1% | 77.5% | 37.3% | 3,015,716.4% | 1,708.3% | 893.2% | 995.8% | 698.1% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | 90,067.4% | – | – | – | – | |
| 510.4% | 10.8% | 242.9% | 662.9% | 578.5% | 245.7% | 5.6% | -1,937,950.7% | 18.8% | 0.0% | – | – | |
| – | – | -0.2% | -0.3% | -0.1% | -0.1% | -0.2% | -1,395.8% | -2.3% | 0.0% | 0.0% | – | |
| 512.8% | 10.8% | 242.9% | 662.9% | 578.5% | 245.6% | 128.7% | -1,849,279.1% | 16.5% | 20.3% | 39.6% | 16.1% | |
| -88.0% | 97.7% | 127.3% | -134.9% | -34.1% | 8.8% | 22.9% | 182,786.4% | -448.5% | -190.3% | -32.8% | 23.8% | |
| -94.2% | -164.3% | 41.0% | -673.9% | -329.9% | -324.6% | -150.0% | -997,515.0% | -2,207.6% | -1,107.5% | -1,072.7% | -698.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.